Melissa Blandford
Oncology · Hudson, FLNPI 1255767158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 53 manufacturers, the largest accounting for just 8.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,076, 6.3 times the $329 reported in 2021.
Across 289 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$504
- AstraZeneca$475
- Gilead$440
- Pfizer$367
- Merck$342
- Bayer$295
- plus $4K from 47 others
What the payments were for
- Food & beverage$5,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,949 in reported general payments places this provider in the 65th percentile of 24 oncology providers in Florida.
Other oncology in Hudson
- Sara BeelerTampa$337K
- Michelle RampersadSebring$34K
- Janell VerkadenOrmond Beach$19K
- Kimberly TopeTampa$16K
- Aaron DohenySt Petersburg$14K
- Naima Vera-SommersTampa$11K
- Amber AlbaughLecanto$9K
- Natalie GessnerClearwater$8K
- Glenda KaminskiLakeland$5K
- Lee PavelBonita Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.